Medical College of Georgia, Department of Medicine
Hematolgy/Oncology A-Z Index | MCG Home  | Site Search
Faculty

Adult Hemophilia Clinic

Solid Tumor Oncology

Bone Marrow Transplantation Program

Cancer Links

Fellowship Program

Sickle Cell Center

MB CCOP

Clinical Trials

Pediatric Oncology

Patient Information

Internal Medicine Residency Program

M.D./Ph.D. Program

MCG Healthcare System

Information and Referrals
Contact Elizabeth Jones at :
Administrative Office
Phone: 
(706) 721-2505 
1-800-736-CARE
Fax: 
(706) 721-8302

Address:
BAA - 5407
1120 15th Street
Augusta, GA 30912-3125



 

 

Fellowship Program

Med-Hematology/Oncology

Abdullah Kutlar, M.D.
Professor
Program Director

      The Division of Hematology/Oncology offers a three-year combined training program in hematology and medical oncology.  The division currently has 15 faculty members (10 full-time clinical, 3 part-time clinical, 2 full-time research) and is approved for a total of six fellowship positions by the ACGME.

      The Division of Hematology and Oncology is dedicated to the care of patients with cancer and blood disorders.  A multi-disciplinary approach to outpatient care is provided in the Comprehensive Cancer Center where medical, surgical, gynecological, and radiation oncologists are available.  The section is participating in clinical protocols and is adding new trials for all major malignancies.  A full service sickle cell center and adult hemophilia clinic are also available.  Cooperation with the community physicians has resulted in MCG seeing the majority of the patients with hemoglobinopathies, coagulation disorders, acute leukemia, and stem cell transplants.  Special areas of faculty member interest and expertise include stem cell transplants, hemoglobinopathies, coagulation, lung cancer, hematologic malignancies, breast cancer, and lymphomas.

      The division provides a forum for the stimulation and exchange of ideas across all medical disciplines, thereby helping to create an academic environment for teaching, research, and improved patient care.  Twice a month journal club is held with the hematologists/oncologists of the medical school, the army hospital, and the community.  A new every other week journal club with primary involvement of the fellows has been initiated this year in which fellows lead the discussion of selected references with participation of faculty.  A series of formal lectures by division faculty and guest faculty of relevant disciplines to cover basic science and clinical topics in both hematology and medical oncology are presented monthly. 

      Fellows are encouraged to participate in ongoing clinical research projects conducted by faculty of the section.  In many cases, these activities result in submission of abstracts to the annual meetings of the American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO).  Basic research is also available in the institution with mentorship provided by faculty of the Institute of Molecular Medicine and Genetics (IMMAG).

      Fellows rotate through the hematology/oncology in-patient service, BMT/Leukemia unit, hematology/oncology consult service, and the VA Medical Center.  Fellows have two half-day clinics per week and follow patients under their own profile longitudinally throughout their training.  Electives are offered in Hematopathology, Sickle Cell, Blood Bank, Cytogenetics, Radiation Oncology, Pediatric Hematology/Oncology, Gynecologic Oncology, and Coagulation Services.

Length:               2 Years Hematology  or 3 Years       
                            Hematology/Medical Oncology

Accepted:             2/Year
NRMP Match:    Yes, 2007

Programs of the Hematology/Oncology Division

 Bone Marrow Transplant
     The BMT program is under the direction of Dr. Anand Jillella.  Both allogeneic and autologous stem cell transplants are offered for the treatment of hematologic malignancies (acute leukemias, chronic myelogenous leukemia, lymphomas, multiple myeloma).  The program will be expanding to perform matched unrelated donor (MUD) and mismatched stem cell transplants and to cover non-malignant hematologic disorders.  Active research programs include novel approaches to myeloma and AML . 

 Oncology Clinical Trials
      The division is involved in numerous clinical trials and participates in both the cooperative studies (NSABP and ECOG) and pharmaceutical sponsored trials.  The oncology clinical trials program is under the direction of Dr. Anand Jillella, Division Director, and has been very active, particularly in the areas of breast and lung cancer.  Fellows are encouraged to have first-hand experience in the conductance of Phase II/III clinical trials.  A Minority based Community Clinical Oncology Program has been funded by the National Cancer Institute

 Sickle Cell Center
      The Sickle Cell Center has a large pediatric and adult clinical program and a hemoglobinopathy reference laboratory.  The Center, under the direction of Dr. Abdullah Kutlar, is involved in many clinical studies.  The laboratory provides reference testing for hemoglobinopathies for the State of Georgia as well as for many institutions in the country and serves as the core laboratory for several multicenter trials.  The laboratory utilizes state-of-the art methods including genetic methods in the diagnosis of hemoglobinopathies and identification of new mutations.  The center’s current research interests are on genetic modifiers of the clinical phenotype in sickle cell disease.  An elective in the sickle cell program is offered to the fellows and fellows are encouraged to participate in the center’s ongoing research activities. 

Hemophilia Program
     The Hemophilia Program follows approximately 100 patients with inherited bleeding disorders (hemophilia and von Willebrand disease) in the area and is under the direction of Dr. Charles Lutcher and Dr. Kavita Natarajan.  It offers comprehensive services to the patients including education and social work.  Fellows can do electives in the hemophilia/coag program

Copyright
Medical College of Georgia
All rights reserved.

Department of Medicine | Medical College of Georgia
Please email questions and comments to:

June 08, 2007